Federal Circuit endorses ‘holistic’ approach to assessing US domestic industry
A final determination by the US International Trade Commission that Wuhan Healthgen Biotechnology infringed a valid Ventria Bioscience patent won’t be disturbed. In a precedential ruling today, the US Court of...To view the full article, register now.
Already a subscriber? Click here to view full article